DBV Technologies | DBVT - Pasivo Circulante





Pasivo Circulante Cambio Fecha
Acadia Pharmaceuticals USD 332.22M 29.22M 2026-09
Alnylam Pharmaceuticals USD 2.06B 550.49M 2026-09
Amarin USD 175.14M 10.94M 2026-09
BioCryst Pharmaceuticals USD 195.83M 13.02M 2026-09
BioMarin Pharmaceutical USD 1.6B 59.17M 2026-09
DBV Technologies USD 58.5M 4.2M 2026-09
Galectin Therapeutics USD 14.62M 1.98M 2024-06
Halozyme Therapeutics USD 476.09M 131.65M 2026-09
Incyte USD 1.44B 125.72M 2026-09
Insmed USD 596.57M 157.83M 2026-09
Ionis Pharmaceuticals USD 435.29M 119.65M 2026-09
Neurocrine Biosciences USD 984.6M 110.1M 2026-09
PTC Therapeutics USD 776.08M 5.01M 2026-09
Sarepta Therapeutics USD 656.35M 153.44M 2026-09
Ultragenyx Pharmaceutical USD 389M 38M 2026-09
United Therapeutics USD 624.3M 16.5M 2026-09